Our findings that the patients with germline homozygous HAVCR2 mutation were able to present with idiopathic HLH/HLH-like systemic illnesses before the onset of SPTCL help confirm this hypothesis. The gene discussed is HAVCR2; the disease is hemophagocytic syndrome.